News
The European Medicines Agency has recommended authorizing a twice-yearly injectable drug to prevent HIV. Scientists say this ...
The European Union's drugs regulator has recommended approval of Gilead Sciences' lenacapavir, a twice-yearly injection, for ...
An epidemic that's been sustained for 44 years might finally be quelled, with the milestone approval of the first HIV drug ...
2don MSN
The Republican-led Senate rescued funding for PEPFAR in a package of spending cuts last month, but the HIV-prevention program ...
DAP Health has received the new twice-yearly injection for HIV prevention. Here's what you need to know if you're interested ...
The drug is administered subcutaneously twice a year, making it easier for high-risk patients to comply with prophylaxis.
President Donald Trump is removing a large portion of HIV funding he previously greenlit for a future without AIDs. For ...
Gilead Sciences (GILD) stock gains as Needham upgrades the company to Buy from Hold citing its new HIV prevention injectable, ...
Experts welcome the news that PEPFAR funding remains intact, but few details about how and where services will be ...
4d
Cuts outlined in President Donald Trump’s proposed 2026 budget mean some groups stand to lose federal funds that support services like testing and HIV treatment.
Just diagnosed with HIV? We have answers to your most commonly-asked questions, including what it means to be "undetectable." ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results